Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Discovery
Cancer Discovery
  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

Research Watch

Chromosomal Translocations Are Mediated by Canonical NHEJ in Human Cells

DOI: 10.1158/2159-8290.CD-RW2014-197 Published November 2014
  • Article
  • Info & Metrics
Loading
  • Major finding: In contrast to mice, human cells require canonical NHEJ for DSB-induced chromosomal translocations.

  • Approach: DNA nucleases were used to induce translocations in human cells lacking NHEJ components.

  • Impact: Species-specific mechanisms generating chromosomal rearrangements likely influence carcinogenesis.

Reciprocal chromosomal translocations are frequently observed in cancer cells and are responsible for generating oncogenic fusion genes as well as driving proto-oncogene expression. Previous studies have shown that, in murine cells, the canonical nonhomologous end-joining (NHEJ) pathway suppresses chromosomal translocations, which are instead mediated by alternative NHEJ. Interestingly, however, breakpoints characterized in human cells do not always display significant regions of microhomology, which are typically associated with alternative NHEJ activity, prompting Ghezraoui and colleagues to study the relative contribution of canonical and alternative NHEJ in chromosomal translocations in human cells. To address the role of the canonical NHEJ pathway in translocation formation, a series of zinc finger and transcription activator–like effector (TALE) nucleases designed to generate site-specific double-strand breaks (DSB) were expressed in a variety of human cell lines deficient for the canonical NHEJ components DNA ligase IV (LIG4) or X-ray repair cross-complementing protein 4 (XRCC4). Analysis of the resulting junctions showed that loss of canonical NHEJ led to reduced translocation frequency, longer deletions, and larger regions of microhomology. Similar experiments performed using patient-derived fibroblasts that harbor hypomorphic LIG4 mutations revealed that reduced canonical NHEJ activity led to an intermediate translocation phenotype. Expanding on these findings, Cas9-induced DSBs or paired DNA nicks, but not singly nicked DNA, mediated formation of the oncogenic NPM–ALK translocation, which was also dependent on canonical NHEJ. Importantly, loss of DNA ligase III (LIG3), which promotes alternative NHEJ and murine translocations, did not impair the translocation frequency or alter translocation junction characteristics in human cells. Moreover, suppression of the alternative NHEJ DNA resection factor, retinoblastoma binding protein 8 (also known as CtIP), decreased translocation frequency in human cells only when canonical NHEJ activity was also reduced. Together, these results indicate that the canonical NHEJ pathway predominantly drives chromosomal translocations in human cells and highlights a species-specific difference in chromosomal rearrangement mechanisms.

Ghezraoui H, Piganeau M, Renouf B, Renaud JB, Sallmyr A, Ruis B, et al. Chromosomal translocations in human cells are generated by canonical nonhomologous end-joining. Mol Cell 2014 Sep 4 [Epub ahead of print].

  • ©2014 American Association for Cancer Research.
PreviousNext
Back to top
Cancer Discovery: 4 (11)
November 2014
Volume 4, Issue 11
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Chromosomal Translocations Are Mediated by Canonical NHEJ in Human Cells
(Your Name) has forwarded a page to you from Cancer Discovery
(Your Name) thought you would be interested in this article in Cancer Discovery.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Chromosomal Translocations Are Mediated by Canonical NHEJ in Human Cells
Cancer Discov November 1 2014 (4) (11) OF12; DOI: 10.1158/2159-8290.CD-RW2014-197

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Chromosomal Translocations Are Mediated by Canonical NHEJ in Human Cells
Cancer Discov November 1 2014 (4) (11) OF12; DOI: 10.1158/2159-8290.CD-RW2014-197
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Research Watch

  • In Vivo CRISPR Screen Identifies FLI1 as Regulator of Effector T Cells
  • Trial Supports Combination Treatment and New Target for Multiple Myeloma
  • Mitochondrial DNA Damage Triggers an IFN-Mediated Immune Response
Show more Research Watch

DNA Repair

  • Histone Methylation Connects DNA Repair to Metabolism in Cancer Cells
  • Release of Paused Pol II Induces Double-Strand Breaks in Normal Cells
  • UBQLN4 Regulates DNA Repair Pathway Choice
Show more DNA Repair
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue
  • Past Issues

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Discovery

  • About the Journal
  • Editors
  • Journal Sections
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Advertisement